TSBX
Turnstone Biologics
TSBX
TSBX
Delisted
TSBX was delisted on the 8th of August, 2025.
36 hedge funds and large institutions have $33.1M invested in Turnstone Biologics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 35 → 36 (+1)
31% less capital invested
Capital invested by funds: $48M → $33.1M (-$14.9M)
Holders
36
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.36M | |
| 2 | +$491K | |
| 3 | +$303K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$156K |
| 5 |
Morgan Stanley
New York
|
+$74.4K |
Top Sellers
| 1 | -$2.33M | |
| 2 | -$740K | |
| 3 | -$244K | |
| 4 |
Two Sigma Investments
New York
|
-$171K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$141K |